Free Trial

Public Employees Retirement System of Ohio Invests $3.25 Million in Balchem Co. (NASDAQ:BCPC)

Balchem logo with Basic Materials background

Public Employees Retirement System of Ohio purchased a new stake in Balchem Co. (NASDAQ:BCPC - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 19,913 shares of the basic materials company's stock, valued at approximately $3,246,000. Public Employees Retirement System of Ohio owned approximately 0.06% of Balchem as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds have also modified their holdings of the company. Congress Asset Management Co. grew its stake in shares of Balchem by 5.4% in the fourth quarter. Congress Asset Management Co. now owns 317,610 shares of the basic materials company's stock valued at $51,769,000 after acquiring an additional 16,170 shares in the last quarter. Apollon Wealth Management LLC acquired a new position in shares of Balchem in the fourth quarter valued at about $503,000. Charles Schwab Investment Management Inc. lifted its position in Balchem by 2.5% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 370,912 shares of the basic materials company's stock worth $60,457,000 after purchasing an additional 8,942 shares during the period. Man Group plc bought a new stake in Balchem during the fourth quarter worth about $461,000. Finally, Victory Capital Management Inc. lifted its position in Balchem by 25.9% during the fourth quarter. Victory Capital Management Inc. now owns 124,413 shares of the basic materials company's stock worth $20,279,000 after purchasing an additional 25,560 shares during the period. 87.91% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several equities research analysts recently weighed in on the stock. HC Wainwright set a $180.00 price objective on shares of Balchem and gave the stock a "buy" rating in a research report on Monday, April 28th. Sidoti raised shares of Balchem to a "hold" rating in a report on Tuesday, February 25th. Finally, Wall Street Zen cut shares of Balchem from a "buy" rating to a "hold" rating in a report on Wednesday, May 21st.

Get Our Latest Analysis on Balchem

Balchem Trading Down 0.2%

NASDAQ BCPC traded down $0.35 during trading hours on Wednesday, reaching $166.29. The company's stock had a trading volume of 106,575 shares, compared to its average volume of 138,728. The firm has a fifty day simple moving average of $162.19 and a 200-day simple moving average of $165.59. The stock has a market cap of $5.42 billion, a P/E ratio of 42.31, a P/E/G ratio of 4.41 and a beta of 0.93. Balchem Co. has a 52 week low of $145.70 and a 52 week high of $186.03. The company has a debt-to-equity ratio of 0.19, a current ratio of 1.99 and a quick ratio of 1.16.

Balchem (NASDAQ:BCPC - Get Free Report) last released its earnings results on Thursday, April 24th. The basic materials company reported $1.22 earnings per share for the quarter, missing analysts' consensus estimates of $1.25 by ($0.03). The firm had revenue of $250.52 million for the quarter, compared to analyst estimates of $245.70 million. Balchem had a net margin of 13.47% and a return on equity of 11.37%. The business's revenue for the quarter was up 4.5% compared to the same quarter last year. During the same period in the prior year, the company posted $1.03 EPS. Equities analysts forecast that Balchem Co. will post 4.64 earnings per share for the current fiscal year.

About Balchem

(Free Report)

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.

See Also

Institutional Ownership by Quarter for Balchem (NASDAQ:BCPC)

Should You Invest $1,000 in Balchem Right Now?

Before you consider Balchem, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Balchem wasn't on the list.

While Balchem currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Dirt-Cheap Stocks in a Market That’s Getting Expensive
Top 3 Defense Stocks to Profit From $175 Billion Golden Dome
Top 5 Stocks for June: AI Picks That Aren’t NVIDIA

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines